Posted by Michael Wonder on 14 Jul 2022
Breakthrough treatment to boost life chances for hundreds of people with respiratory cancer
14 July 2022 - The first new mesothelioma treatment to be approved in nearly 15 years will be made available for hundreds of patients with aggressive respiratory cancer, the NHS announced today.
The life extending treatment, which has been approved for use today by NICE after the NHS struck a new commercial deal for the medicines, will combine nivolumab and ipilimumab and will be offered on the NHS immediately, benefitting around 1,000 patients in England each year.
